NASDAQ: SION
Sionna Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for SION

Based on 1 analyst offering 12 month price targets for Sionna Therapeutics Inc

Min Forecast
$32.00+183.19%
Avg Forecast
$32.00+183.19%
Max Forecast
$32.00+183.19%

Should I buy or sell SION stock?

Based on 1 analyst offering ratings for Sionna Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SION's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SION as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SION stock forecasts and price targets.

SION stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-04

1 of 1

Forecast return on equity

Is SION forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is SION forecast to generate an efficient return on assets?

Company
-55.59%
Industry
1,136.33%
SION is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SION earnings per share forecast

What is SION's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$2.20
Avg 2 year Forecast
-$2.34

SION vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SION$11.30$32.00+183.19%Strong Buy
KURA$6.18$26.43+327.65%Strong Buy
PRTA$9.30$54.57+486.78%Buy
COGT$4.30$15.00+248.84%Buy
NAGE$6.53$9.03+38.33%Strong Buy

Sionna Therapeutics Stock Forecast FAQ

Is Sionna Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SION) stock is to Strong Buy SION stock.

Out of 1 analyst, 1 (100%) are recommending SION as a Strong Buy, 0 (0%) are recommending SION as a Buy, 0 (0%) are recommending SION as a Hold, 0 (0%) are recommending SION as a Sell, and 0 (0%) are recommending SION as a Strong Sell.

If you're new to stock investing, here's how to buy Sionna Therapeutics stock.

What is SION's earnings growth forecast for 2025-2026?

(NASDAQ: SION) Sionna Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Sionna Therapeutics's earnings in 2025 is -$61,688,000.On average, 2 Wall Street analysts forecast SION's earnings for 2025 to be -$97,073,667, with the lowest SION earnings forecast at -$98,838,643, and the highest SION earnings forecast at -$95,308,691.

In 2026, SION is forecast to generate -$103,251,082 in earnings, with the lowest earnings forecast at -$106,781,033 and the highest earnings forecast at -$99,721,130.

What is SION's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SION) forecast ROE is N/A, which is considered weak.

What is SION's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SION price target, the average SION price target is $32.00, with the highest SION stock price forecast at $32.00 and the lowest SION stock price forecast at $32.00.

The Wall Street analyst predicted that Sionna Therapeutics's share price could reach $32.00 by Mar 4, 2026. The average Sionna Therapeutics stock price prediction forecasts a potential upside of 183.19% from the current SION share price of $11.30.

What is SION's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: SION) Sionna Therapeutics's current Earnings Per Share (EPS) is -$15.99. On average, analysts forecast that SION's EPS will be -$2.20 for 2025, with the lowest EPS forecast at -$2.24, and the highest EPS forecast at -$2.16. In 2026, SION's EPS is forecast to hit -$2.34 (min: -$2.42, max: -$2.26).

What is SION's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SION) forecast ROA is -55.59%, which is lower than the forecast US Biotechnology industry average of 1,136.33%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.